Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/5914
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChang, Aileen Y.-
dc.contributor.authorKarwa, Rakhi-
dc.contributor.authorOdhiambo, Haji-
dc.contributor.authorWere, Phelix-
dc.contributor.authorFletcher, Sara L.-
dc.contributor.authorTonui, Edith C.-
dc.contributor.authorKohn, Michael A.-
dc.contributor.authorLee, Jeannette-
dc.contributor.authorChang, Di-
dc.contributor.authorLensing, Shelly-
dc.contributor.authorNamaemba, Diana Flora-
dc.contributor.authorBusakhala, Naftali-
dc.contributor.authorKiprono, Samson K.-
dc.contributor.authorMaurer, Toby-
dc.contributor.authorGoodrich, suzanne-
dc.contributor.authorPastakia, Sonak D.-
dc.date.accessioned2022-02-02T09:22:34Z-
dc.date.available2022-02-02T09:22:34Z-
dc.date.issued2022-02-02-
dc.identifier.uriDOI https://doi.org/10.1200/GO.21.00329.-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/5914-
dc.description.abstractbstract PURPOSE Evaluate the effectiveness of compression while receiving chemotherapy compared with chemo therapy alone in the treatment of HIV-associated Kaposi sarcoma (KS) lymphedema. METHODS A randomized controlled trial was conducted in a single oncology clinic in western Kenya (NCT03404297). A computer-generated randomization schedule was used to allocate treatment arms. Randomized block design was used for stratification by lymphedema stage. Participants were HIV positive adults age ≥ 18 years on antiretroviral therapy with biopsy-proven KS associated with leg lymphedema and being initiated on chemotherapy. The intervention was 10 weeks of weekly clinic-based application of two-component paste compression bandages. The primary outcome was change in the Lower Extremity Lymphedema Index (LELI) score from week 0 to week 14. The secondary outcomes were change in the Lymphedema Quality of Life measure (LYMQOL) and change in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 score from week 0 to week 14. Blinded outcome assessments were conducted. RESULTS Of 30 participants randomly assigned, 25 eligible patients (chemotherapy [control], n = 13; com pression plus chemotherapy [intervention], n = 12) returned at week 14. Change in LELI, LYMQOL, and EORTC QLQ-C30 scores between week 14 and week 0 did not significantly differ by arm. The mean (standard deviation) change in LELI score was –25.9 (34.6) for the control arm compared with –13.3 (29.5) for the intervention arm, P = .340. The difference (95% CI) in the change in LELI score was –12.6 (–39.3 to 14.1). CONCLUSION Future studies evaluating a 14-week change in LELI for KS lymphedema should assume a standard deviation of approximately 30. Lessons learned from this pilot trial should inform the development of a larger, multicenter trial to evaluate the effectiveness of compression for KS lymphedemaen_US
dc.description.sponsorshipToby Maurer, Sonak D. Pastakiaen_US
dc.language.isoenen_US
dc.publisherAmerican society of clinical oncologyen_US
dc.subjectKaposi Sarcoma Leg Lymphedemaen_US
dc.subjectHIVen_US
dc.subjectChemotherapyen_US
dc.titleCompression therapy for HIV-associated Kaposi Sarcoma leg lymphedema: results of the Kenyan improvised compression for Kaposi Sarcoma randomized controlled trialen_US
dc.title.alternativeRakhi Karwaen_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.